When.com Web Search

  1. Ads

    related to: singulair where to buy near me

Search results

  1. Results From The WOW.Com Content Network
  2. Montelukast - Wikipedia

    en.wikipedia.org/wiki/Montelukast

    Montelukast, sold under the brand name Singulair among others, is a medication used in the maintenance treatment of asthma. [6] It is generally less preferred for this use than inhaled corticosteroids. [6] It is not useful for acute asthma attacks. [6] Other uses include allergic rhinitis and hives of long duration. [6]

  3. Popular asthma drug Singulair could be linked to mental ... - AOL

    www.aol.com/popular-asthma-drug-singulair-could...

    Singulair, originally sold by Merck & Co., is a prescription drug that was launched in 1998 and is used to prevent and treat symptoms of asthma and allergies, according to the Cleveland Clinic, by ...

  4. Exclusive-US FDA finds widely used asthma drug impacts ... - AOL

    www.aol.com/news/exclusive-us-fda-finds-widely...

    By 2019, the FDA tallied 82 suicides linked to Singulair and its generic versions reported to its adverse-event database since 1998. At least 31 of those reports involved someone age 19 or younger.

  5. Zafirlukast - Wikipedia

    en.wikipedia.org/wiki/Zafirlukast

    Zafirlukast is FDA-approved for the prevention and treatment of asthma in adults and children older than 5 years old. [1] Like other leukotriene receptor antagonists, zafirlukast is thought to be useful for the long-term treatment of asthma, but it is generally less effective than inhaled glucocorticoids as monotherapy (which are the standard of care) or long-acting beta-2 agonists in ...

  6. Teva Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Teva_Pharmaceuticals

    In April, Teva offered to acquire Mylan for $40 billion, [41] only a fortnight after Mylan offered to buy Perrigo for $29 billion. [42] Teva's offer for Mylan was contingent on Mylan abandoning its pursuit of Perrigo. [43] Mylan stated in June 2015 that Teva's disclosure that it had a 1.35 percent stake in Mylan violated US antitrust rules. [44]

  7. FDA approves opioid-free pain medication with 'no sign of ...

    www.aol.com/fda-approves-opioid-free-pain...

    A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...